Assignee
TEVA PHARMA
IL·400 granted patents·140 pending applications·7,397 citations·filing 1978–2023
Top patents by PatentIndex Score
540 records- 0197US8591463B1Re-useable injector device for syringeTEVA PHARMA·Filed 2013·Granted Nov 26, 2013·85 cites·18 claims
- 0297US7750051B2Crystalline solid rasagiline baseTEVA PHARMA·Filed 2007·Granted Jul 6, 2010·35 cites·14 claims
- 0397US7056942B2CarvedilolTEVA PHARMA·Filed 2004·Granted Jun 6, 2006·358 cites·5 claims
- 0497US6630514B2Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereofTEVA PHARMA·Filed 2001·Granted Oct 7, 2003·77 cites·36 claims
- 0597US6495721B1Sertraline hydrochloride Form II and methods for the preparation thereofTEVA PHARMA·Filed 2000·Granted Dec 17, 2002·58 cites·22 claims
- 0697US5877218ACompositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivativesTEVA PHARMA·Filed 1995·Granted Mar 2, 1999·153 cites·19 claims
- 0797US5532415AR-enantiomer of N-propargyl-1-aminoindan, salts, compositions and uses thereofTEVA PHARMA·Filed 1995·Granted Jul 2, 1996·169 cites·1 claims
- 0897US5519061AR-enantiomer of n-propargyl-1-aminoindan, salts, compositions and uses thereofTEVA PHARMA·Filed 1995·Granted May 21, 1996·139 cites·9 claims
- 0996US7855233B2Citrate salt of RasagilineTEVA PHARMA·Filed 2010·Granted Dec 21, 2010·34 cites·16 claims
- 1096US7619117B1Rasagiline formulations and processes for their preparationTEVA PHARMA·Filed 2008·Granted Nov 17, 2009·39 cites·11 claims
- 1196US7495072B2Process for preparation of mixtures of polypeptides using purified hydrobromic acidTEVA PHARMA·Filed 2005·Granted Feb 24, 2009·51 cites·21 claims
- 1296US7195778B2Drug delivery system for zero order, zero order-biphasic, ascending or descending drug deliveryTEVA PHARMA·Filed 2002·Granted Mar 27, 2007·177 cites·44 claims
- 1396US6777552B2Processes for preparing calcium salt forms of statinsTEVA PHARMA·Filed 2002·Granted Aug 17, 2004·66 cites·41 claims
- 1496US5457133AR-enantiomers of N-propargyl-aminoindan compounds, their preparation and pharmaceutical compositions containing themTEVA PHARMA·Filed 1994·Granted Oct 10, 1995·112 cites·14 claims
- 1596US5453446AUse of the R-enantiomers of N-propargyl 1-aminoindan compounds for treating Parkinson's disease.TEVA PHARMA·Filed 1994·Granted Sep 26, 1995·104 cites·20 claims
- 1695US7923215B2Process for the measurement of the potency of glatiramer acetateTEVA PHARMA·Filed 2008·Granted Apr 12, 2011·32 cites·30 claims
- 1795US7547806B2Tannate salt of rasagilineTEVA PHARMA·Filed 2007·Granted Jun 16, 2009·44 cites·13 claims
- 1895US6528685B2Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivativesTEVA PHARMA·Filed 1999·Granted Mar 4, 2003·47 cites·25 claims
- 1995US5914349ACompositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivativesTEVA PHARMA·Filed 1995·Granted Jun 22, 1999·50 cites·18 claims
- 2095US5891923AR-enantiomer of N-propargyl-1-aminoindan for the treatment of dementiaTEVA PHARMA·Filed 1995·Granted Apr 6, 1999·97 cites·10 claims
- 2195US5877221ACompositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivativesTEVA PHARMA·Filed 1997·Granted Mar 2, 1999·52 cites·29 claims
- 2295US5786390APharmaceutical compositions of the R-enantiomer of N-propargyl -1-aminoindanTEVA PHARMA·Filed 1995·Granted Jul 28, 1998·105 cites·19 claims
- 2395US5744500AUse of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereofTEVA PHARMA·Filed 1995·Granted Apr 28, 1998·100 cites·39 claims
- 2495US5668181AUse of the R-enantiomers of N-propargyl-1-aminoindan compounds for the treatment of depressionTEVA PHARMA·Filed 1995·Granted Sep 16, 1997·92 cites·7 claims
- 2595US5639913AMethod for preparing optically active 1-aminoindan derivativesTEVA PHARMA·Filed 1996·Granted Jun 17, 1997·63 cites·38 claims
- 2695US5576353AMethod of treating memory disorders using R-enantiomers of N-propargyl-aminoindan compoundsTEVA PHARMA·Filed 1995·Granted Nov 19, 1996·101 cites·7 claims
- 2795US5466683AWater-soluble analogs of carbamazepineTEVA PHARMA·Filed 1994·Granted Nov 14, 1995·74 cites·17 claims
- 2895US5387612AUse of the R-enantiomers of N-propargyl-1-aminoindan compounds for treating Parkinson's diseaseTEVA PHARMA·Filed 1993·Granted Feb 7, 1995·114 cites·9 claims
- 2994US7687636B2Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparationTEVA PHARMA·Filed 2006·Granted Mar 30, 2010·11 cites·3 claims
- 3094US7598420B1Rasagiline formulations and processes for their preparationTEVA PHARMA·Filed 2008·Granted Oct 6, 2009·46 cites·20 claims
- 3194US7589211B2Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparationTEVA PHARMA·Filed 2006·Granted Sep 15, 2009·10 cites·3 claims
- 3294US7582768B2Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparationTEVA PHARMA·Filed 2006·Granted Sep 1, 2009·11 cites·3 claims
- 3394US7572834B1Rasagiline formulations and processes for their preparationTEVA PHARMA·Filed 2006·Granted Aug 11, 2009·49 cites·12 claims
- 3494US7435827B2Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparationTEVA PHARMA·Filed 2006·Granted Oct 14, 2008·11 cites·2 claims
- 3594US7151183B2Processes for preparing amorphous atorvastatin hemi-calciumTEVA PHARMA·Filed 2005·Granted Dec 19, 2006·11 cites·5 claims
- 3694US6881420B2Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferationTEVA PHARMA·Filed 2001·Granted Apr 19, 2005·58 cites·25 claims
- 3794US6696600B2L-DOPA ethyl ester salts and uses thereofTEVA PHARMA·Filed 2002·Granted Feb 24, 2004·42 cites·20 claims
- 3894US6306436B1Stabilized, acid-free formulation for sustained release of bupropion hydrochlorideTEVA PHARMA·Filed 2000·Granted Oct 23, 2001·136 cites·36 claims
- 3994US5994408ACompositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivativesTEVA PHARMA·Filed 1997·Granted Nov 30, 1999·54 cites·32 claims
- 4094US5599991AEsylate and sulfate salts of R(+)-N-propargyl-1-aminoindanTEVA PHARMA·Filed 1995·Granted Feb 4, 1997·84 cites·2 claims
- 4193USD827127SInjector penTEVA PHARMA·Filed 2016·Granted Aug 28, 2018·74 cites·1 claims
- 4293US7884208B2Crystals of laquinimod sodium, and process for the manufacture thereofTEVA PHARMA·Filed 2006·Granted Feb 8, 2011·27 cites·8 claims
- 4393US7429374B2Process for the measurement of the potency of glatiramer acetateTEVA PHARMA·Filed 2002·Granted Sep 30, 2008·41 cites·9 claims
- 4493US7250533B2Process for preparing Cinacalcet hydrochlorideTEVA PHARMA·Filed 2006·Granted Jul 31, 2007·25 cites·45 claims
- 4593US6528661B2Hydrolysis of [R(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino) carbonyl]-1H-pyrrole-1-heptanoic acid esters with calcium hydroxideTEVA PHARMA·Filed 2001·Granted Mar 4, 2003·64 cites·22 claims
- 4693US5880159ACompositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivativesTEVA PHARMA·Filed 1997·Granted Mar 9, 1999·47 cites·29 claims
- 4792US8652100B1Re-useable injector device for syringeTEVA PHARMA·Filed 2013·Granted Feb 18, 2014·41 cites·24 claims
- 4892US7973045B2Anhydrous form of dasatinib and process for preparation thereofTEVA PHARMA·Filed 2010·Granted Jul 5, 2011·35 cites·9 claims
- 4992US7491847B2Methods for isolating propargylated aminoindansTEVA PHARMA·Filed 2006·Granted Feb 17, 2009·55 cites·37 claims
- 5092US7446220B2Asymmetric synthesis of (S)-(+)-3-(aminomethyl)-5-methylhexanoic acidTEVA PHARMA·Filed 2006·Granted Nov 4, 2008·9 cites·5 claims
Showing the top 50 of 540 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when TEVA PHARMA files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →